A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.
The United States and many other countries are heavily dependent on supplies of pharmaceuticals and precursor chemicals from China and India. Widespread shortages resulting from the COVID-19 outbreak remain unlikely. Legislative proposals in the United States to force companies to "reshore" supply chains will likely falter on the increase in costs and regulatory hurdles. ...
Already a subscriber? Sign in
Copyright © Stratfor, an operating unit of RANE Network Inc.